Vaccinia virus complement control protein ameliorates hyperacute xenorejection by inhibiting xenoantibody binding.
Anderson
J B
JB
Department of Microbiology, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.
Smith
S A
SA
van Wijk
R
R
Chien
S
S
Kotwal
G J
GJ
D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood*; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D051379:Mice; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000627:therapeutic use; D014183:Transplantation, Heterologous / Q000276:immunology*; D014764:Viral Proteins / Q000627:therapeutic use*
D000910:Antibodies, Heterophile; D011994:Recombinant Proteins; D014764:Viral Proteins; C066459:complement-control protein, Vaccinia virus